112 related articles for article (PubMed ID: 25537374)
1. Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques.
Grandin C; Lucas-Hourani M; Clavel M; Taborik F; Vabret A; Tangy F; Contamin H; Vidalain PO
J Gen Virol; 2015 Apr; 96(Pt 4):782-792. PubMed ID: 25537374
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.
Chan KF; Carolan LA; Druce J; Chappell K; Watterson D; Young P; Korenkov D; Subbarao K; Barr IG; Laurie KL; Reading PC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187546
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors.
Grandin C; Hourani ML; Janin YL; Dauzonne D; Munier-Lehmann H; Paturet A; Taborik F; Vabret A; Contamin H; Tangy F; Vidalain PO
Antiviral Res; 2016 Jan; 125():58-62. PubMed ID: 26593978
[TBL] [Abstract][Full Text] [Related]
5. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
[TBL] [Abstract][Full Text] [Related]
6.
Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644
[TBL] [Abstract][Full Text] [Related]
7. High Resolution Analysis of Respiratory Syncytial Virus Infection In Vivo.
Aljabr W; Armstrong S; Rickett NY; Pollakis G; Touzelet O; Cloutman-Green E; Matthews DA; Hiscox JA
Viruses; 2019 Oct; 11(10):. PubMed ID: 31658630
[TBL] [Abstract][Full Text] [Related]
8. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
Farrag MA; Almajhdi FN
Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
[TBL] [Abstract][Full Text] [Related]
9. The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.
Xu ML; Kim HJ; Wi GR; Kim HJ
J Microbiol; 2015 Sep; 53(9):661-6. PubMed ID: 26310306
[TBL] [Abstract][Full Text] [Related]
10. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
Sarkar I; Garg R; van Drunen Littel-van den Hurk S
Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
[TBL] [Abstract][Full Text] [Related]
11. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
12. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.
Guo-Parke H; Canning P; Douglas I; Villenave R; Heaney LG; Coyle PV; Lyons JD; Shields MD; Power UF
Am J Respir Crit Care Med; 2013 Oct; 188(7):842-51. PubMed ID: 23952745
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T cell immunity against human respiratory syncytial virus.
Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
[TBL] [Abstract][Full Text] [Related]
14. Central Role of the NF-κB Pathway in the
Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.
Ebihara T; Endo R; Kikuta H; Ishiguro N; Ishiko H; Kobayashi K
J Med Virol; 2004 Feb; 72(2):304-6. PubMed ID: 14695674
[TBL] [Abstract][Full Text] [Related]
16. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
Chang JS; Wang KC; Shieh DE; Chiang LC
J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
[TBL] [Abstract][Full Text] [Related]
17. Transmission of Human Respiratory Syncytial Virus in the Immunocompromised Ferret Model.
de Waal L; Smits SL; Veldhuis Kroeze EJB; van Amerongen G; Pohl MO; Osterhaus ADME; Stittelaar KJ
Viruses; 2018 Jan; 10(1):. PubMed ID: 29301313
[TBL] [Abstract][Full Text] [Related]
18. Immune monitoring of children with respiratory syncytial virus infection.
Mejias A; Hall MW; Ramilo O
Expert Rev Clin Immunol; 2013 May; 9(5):393-5. PubMed ID: 23634732
[No Abstract] [Full Text] [Related]
19. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection.
Weltzin R; Traina-Dorge V; Soike K; Zhang JY; Mack P; Soman G; Drabik G; Monath TP
J Infect Dis; 1996 Aug; 174(2):256-61. PubMed ID: 8699052
[TBL] [Abstract][Full Text] [Related]
20. Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines.
Bastien N; Trudel M; Simard C
Vaccine; 1999 Feb; 17(7-8):832-6. PubMed ID: 10067688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]